Apr 14, 2021 | Articles, CLIA, ColoPlex, Colorectal Cancer, Company Details, COVID-19, Featured, News and Events
EDP Biotech Finalist in MedCity INVEST Pitch Perfect Diagnostic Track In the age of COVID, diagnostics have become more valuable than ever. EDP Biotech has been fortunate to advance diagnostic programs in colorectal cancer and COVID testing during the last year, and...
Mar 2, 2021 | Articles, Clinical Trials, COVID-19, Featured, News and Events
INSFRASTRUCTURE, TECHNOLOGY AND REGULATION FOR DCTs In this presentation, we discuss how decentralized clinical trials provide better patient engagement by removing common barriers that can have a negative impact on recruitment and retention. We examine various...
Jan 8, 2021 | COVID-19, Featured, News and Events
EDP Biotech to compete in 2021 Tennessee Titans Pitch for Good! The Tennessee Titans and Nashville Entrepreneur Center (NEC) have launched a collaborative partnership to identify and honor Nashville’s top entrepreneur/small business. The Pitch for Good:...
Dec 14, 2020 | ColoPlex, Colorectal Cancer, Featured, News and Events
EDP Biotech Poster Presentation at AACC This week the newest data results from EDP Biotech’s multiplex study involving nearly 2,000 individuals from colorectal cancer organized screening are being presented virtually this week at the 2020 American Association...
Dec 8, 2020 | Articles, ColoPlex, Colorectal Cancer, Company Details, COVID-19, Featured, News and Events
NOLABA, Partners Name Winners of Health Innovators Challenge Watch the YouTube video above to hear EDP Biotech and other NOLABA Challenge winners discuss their impact in healthcare. Read full Article on BizNewOrleans.com “The third challenge was a unique...
Nov 18, 2020 | ColoPlex, Colorectal Cancer, Company Details, Featured, News and Events
New Orleans Health Innovators Panel Discussion The third annual New Orleans Health Innovators (NOLAHI) Challenge will take place virtually on Thursday, November 19 and Friday, November 20, 2020. NOLAHI creates strategic partnerships between top emerging companies and...
